Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
5
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
0 competitors in Gastrointestinal Hemorrhage (Clinically Important, Upper)
View Full LandscapeTarget Indication
Gastrointestinal Hemorrhage (Clinically Important, Upper)
Clinical Trial
NCT03374800Last updated: 8/16/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Pantecta Control
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
View on EMASomac Control
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
View on EMAPantoloc Control
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
View on EMAPantozol Control
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
View on EMAControloc Control
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
View on EMA